Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH.
Department of Orthopaedic Surgery, Lenox Hill Hospital, New York, NY.
J Arthroplasty. 2019 Nov;34(11):2737-2743. doi: 10.1016/j.arth.2019.06.044. Epub 2019 Jun 27.
The diagnosis of periprosthetic joint infections (PJIs) continues to be a subject of extensive debate. This is in part due to the lack of a single "gold standard" test, and the marked heterogeneity in the design of studies evaluating the accuracy of different diagnostic modalities. The goal of this review is to critically analyze the evidence cited by the proceedings of the 2013 International Consensus Meeting (ICM) on PJI with regards to the diagnosis of PJI.
References from the Proceedings of the ICM on PJI related to PJI minor criteria were retrieved and manually reviewed. A total of 25 studies were analyzed using a Validated Quality Assessment of Diagnostic Accuracy Studies tool.
A large number of studies were determined to have a high risk of bias for flow and timing domains due to the large numbers of exclusions. Studies of synovial white blood cells count and polymorphonuclear neutrophils percentage suffered from threshold optimization and lack of internal validity. Furthermore, due to the lack of homogeneity across studies, index test and reference standard domains showed high risk of bias for white blood cell/polymorphonuclear neutrophil percentage and the utility histological analysis, respectively. Leukocyte esterase testing lacked standardization with regard to the strip reagent used, and the exclusion of bloody samples limited sample sizes.
The 2013 ICM minor criteria were based on studies with a low quality of evidence. As the committee continues to adjust these guidelines, they should encourage future studies with sound clinical design, patient selection, and testing procedures.
人工关节周围感染(PJI)的诊断仍然是一个广泛争论的问题。这在一定程度上是由于缺乏单一的“金标准”检测方法,以及评估不同诊断方法准确性的研究设计存在明显的异质性。本综述的目的是批判性地分析 2013 年国际 PJI 共识会议(ICM)会议记录中关于 PJI 诊断的证据。
检索与 PJI 次要标准相关的 ICM 会议记录中的参考文献,并进行手动审查。使用经过验证的诊断准确性研究质量评估工具分析了总共 25 项研究。
由于大量排除,大量研究在流量和时间域被确定为高偏倚风险。由于缺乏内部有效性,滑膜白细胞计数和多形核白细胞百分比的研究受到阈值优化和缺乏的影响。此外,由于研究之间缺乏同质性,白细胞/多形核白细胞百分比的指数测试和参考标准域以及组织学分析的实用性分别存在高偏倚风险。白细胞酯酶检测在所用条带试剂方面缺乏标准化,并且排除了血性样本限制了样本量。
2013 年 ICM 次要标准是基于证据质量较低的研究制定的。随着委员会继续调整这些指南,他们应该鼓励未来的研究采用合理的临床设计、患者选择和检测程序。